Get the Stockscreener App
1.21
2.42%
-0.03
Jaguar Health Inc stock is traded at $1.21, with a volume of 58,144.
It is down -2.42% in the last 24 hours and down -39.20% over the past month.
Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.
See More
Previous Close:
$1.24
Open:
$1.22
24h Volume:
58,144
Relative Volume:
0.41
Market Cap:
$4.52M
Revenue:
$10.48M
Net Income/Loss:
$-37.74M
P/E Ratio:
-0.0748
EPS:
-16.1846
Net Cash Flow:
$-29.03M
1W Performance:
-32.02%
1M Performance:
-39.20%
6M Performance:
-71.60%
1Y Performance:
-95.08%
1-Day Range:
$1.13
$1.3075
1-Week Range:
$1.13
$1.98
52-Week Range:
$1.13
$33.25
Jaguar Health Inc Stock (JAGX) Company Profile
Name
Jaguar Health Inc
Sector
Industry
Phone
415-371-8300
Address
200 PINE STREET SUITE 400, SAN FRANCISCO, CA
Compare JAGX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
JAGX
Jaguar Health Inc
|
1.21 | 4.63M | 10.48M | -37.74M | -29.03M | -16.18 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Jaguar Health Inc Stock (JAGX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-07-21 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-11-17 | Initiated | Rodman & Renshaw | Buy |
Jaguar Health Inc Stock (JAGX) Latest News
In Support of Possible Expedited Approval Pathway for Crofelemer for Treatment of Microvillus Inclusion Disease (MVID), Jaguar Health Submits Amended Protocol to FDA for Ongoing Placebo-Controlled Clinical Trial - Wicked Local
Jaguar Health to Hold Investor Webcast Monday, November 17 at 8:30 AM Eastern Regarding Q3 2025 Financials & Corporate Updates - Lubbock Avalanche-Journal
Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Times Herald-Record
Jaguar Health Amends Royalty Interests and Note Terms - MSN
Jaguar Health Reports Third Quarter 2025 Financials: Net Q3 2025 Revenue Up Approximately 4% Versus Net Q2 2025 Revenue - The Tuscaloosa News
Jaguar Health (JAGX) Seeks Expedited FDA Approval for Crofelemer - GuruFocus
JAGXJaguar Health Inc Latest Stock News & Market Updates - Stock Titan
Is Jaguar Health Inc. (1JA0) stock a top hedge fund pickRate Cut & Fast Entry Momentum Alerts - newser.com
Can Jaguar Health Inc. (1JA0) stock stage a strong rebound this quarter2025 EndofYear Setup & Trade Opportunity Analysis - newser.com
Jaguar Health Inc. stock trendline breakdown2025 Sector Review & Stock Portfolio Risk Control - newser.com
What high frequency data says about Jaguar Health Inc.2025 Top Gainers & Fast Gaining Stock Reports - newser.com
Will Jaguar Health Inc. (1JA0) stock beat international competitionTrade Exit Report & Weekly High Conviction Trade Ideas - newser.com
Has Jaguar Health Inc. formed a bullish divergenceWeekly Stock Summary & Weekly Market Pulse Alerts - newser.com
Will Jaguar Health Inc. (1JA0) stock profit from fiscal stimulusJuly 2025 Summary & Safe Capital Preservation Plans - newser.com
Can Jaguar Health Inc. stock surprise with earnings upsideJuly 2025 Macro Moves & Capital Efficiency Focused Ideas - newser.com
Is Jaguar Health Inc. (1JA0) stock a buy before new product rollout2025 Top Gainers & Technical Confirmation Trade Alerts - newser.com
Short interest data insights for Jaguar Health Inc.July 2025 Momentum & Risk Managed Investment Entry Signals - newser.com
What earnings margins imply for Jaguar Health Inc. (1JA0) stock - newser.com
Live market analysis of Jaguar Health Inc.Analyst Downgrade & Safe Capital Preservation Plans - newser.com
Jaguar Health Reports Q3 2025 Financial Results - TipRanks
Jaguar Health Inc Stock (JAGX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.38%
1.42%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):